NDC 85096-301-01 - MENTHOL 5%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85096-301
- Requested NDC
- 85096-301-01
- Package NDCs from labels
- 85096-301-01, 85096-301-30
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2025-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MENTHOL 5% - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2025-08-08 | HUMAN OTC DRUG LABEL |
| MENTHOL 5% - Marcella Health | Marcella Health | 2025-03-14 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85096-301-01 | MENTHOL 5% | 11 g in 1 PATCH | PATCH | 11 | 1 | |
| 85096-301-30 | MENTHOL 5% | 30 in 1 BOX | PATCH | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85096-301-30 | EA - Each | 85096-301 | ecbae30c-0754-4262-b419-113c589dd638 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | 15FIX9V2JP |
| GuruNanda Pain Relief | LIDOCAINE HYDROCHLORIDE | GuruNanda, LLC. | 3ab6a133-8dca-e14e-e063-6394a90a85e7 | 2026-10-26 | Warnings | M017 |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | 15FIX9V2JP |
| Charm Tex FLUORIDE Gel | SODIUM FLUORIDE | Jiangsu Gold Worldworks Household Chemicals Co., Ltd. | 09d47bd7-1438-4ef2-85e0-9cd5eb2f763a | 2026-10-26 | Warnings | M017 |
| Charm Tex FLUORIDE | SODIUM MONOFLUOROPHOSPHATE | Jiangsu Gold Worldworks Household Chemicals Co., Ltd. | 2bddc69a-0c0f-47fc-bc98-90c2ec70dd6f | 2026-10-26 | Warnings | M017 |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Tunyll Capsaicin Cream | CAPSAICIN | Guangzhou Hechuang Commercial Service Co.,Ltd. | 5ea74148-7ebc-ba93-e063-6294a90a1c0f | 2026-10-25 | Warnings | M017 |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-10-25 | Warnings | 4T6H12BN9U |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.